NaF Positron Emission Tomography/Computed Tomography (PET/CT)Imaging to Assess Treatment Responsiveness to TAK-700 in Patients With Castrate Resistant Prostate Cancer (CRPC) With Bone Metastasis
PHASE2
The purpose of this study is to assess whether NaF PET/CT scans can be used...
Diagnosis of Bone Metastases in Breast Cancer: Bone Scintigraphy, Fluoride-PET and FDG-PET
N/A
Breast cancer can metastasize to the bones, which leads to another treatmen...
Status
Unknown
Location
Dep. of Nuclear Medicine & PET, Rigshospitalet
Start Date
2010-10
Trial ID
NCT01224873
[18F]DASA-23 and PET Scan in Evaluating Pyruvate Kinase M2 Expression in Patients With Intracranial Tumors or Recurrent Glioblastoma and Healthy Volunteers
PHASE1
This phase I trial studies how well \[18F\]DASA-23 and positron emission to...
Fluorine F 18 Fluorodopa-Labeled PET Scan in Planning Surgery and Radiation Therapy in Treating Patients With Newly Diagnosed High- or Low-Grade Malignant Glioma
EARLY_PHASE1
RATIONALE: New imaging procedures, such as fluorine F 18 fluorodopa-labeled...
Fluorine F18-EF5 and Fludeoxyglucose F18 Positron Emission Tomography in Assessing Hypoxia and Glycolysis in Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
PHASE1
RATIONALE: Diagnostic procedures, such as positron emission tomography, usi...
Status
Completed
Location
Abramson Cancer Center of the University of Pennsylvania